Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply

JAMA. 2023 Aug 1;330(5):472-473. doi: 10.1001/jama.2023.9538.

Authors

Ewan C Goligher¹, Patrick R Lawler², Ryan Zarychanski³

Affiliations

¹ Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
² McGill University Health Centre, Montreal, Quebec, Canada.
³ Department of Medicine, University of Manitoba, Winnipeg, Canada.

PMID: 37526722
DOI: 10.1001/jama.2023.9538

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anticoagulants* / administration & dosage
Anticoagulants* / therapeutic use
COVID-19* / complications
Heparin* / administration & dosage
Heparin* / therapeutic use
Heparin, Low-Molecular-Weight
Hospitalization
Humans
SARS-CoV-2
Venous Thromboembolism* / drug therapy

Substances

Anticoagulants
Heparin
Heparin, Low-Molecular-Weight